The neurona
l isoform of nitric oxide synthase (nNOS), the enzyme responsib
le for the production of nitricoxide in the centra
l nervous system, represents an attractive tar
get for the treatment of variousneurode
generative disorders. X-ray crysta
l structures of comp
lexes of nNOS with two nNOS-se
lectiveinhibitors, (4
S)-
N-{4-amino-5-[(2-aminoethy
lamino]penty
l}-
N'-nitro
guanidine (
1) and 4-
N-(
N
ges/gifchars/omega.gif" BORDER=0 >-nitro-
L-ar
gininy
l)-
trans-4-amino-
L-pro
line amide (
2),
led to the discovery of a conserved structura
l water mo
lecu
lethat was hydro
gen bonded between the two heme propionates and the inhibitors (Fi
gure 2). On the basis ofthis observation, we hypothesized that by attachin
g a hydro
gen bond donor
group to the amide nitro
gen of
2 or to the secondary amine nitro
gen of
1, the inhibitor mo
lecu
les cou
ld disp
lace the structura
l water mo
lecu
leand obtain a direct interaction with the heme cofactor. To test this hypothesis, peptidomimetic ana
lo
gues
3-5, which have either an
N-hydroxy
l (
3 and
5) or
N-amino (
4) donor
group, were desi
gned and synthesized.X-ray crysta
l structures of nNOS with inhibitors
3 and
5 bound verified that the
N-hydroxy
l group had,indeed, disp
laced the structura
l water mo
lecu
le and provided a direct interaction with the heme propionatemoiety (Fi
gures 5 and 6). Surprisin
gly, in vitro activity assay resu
lts indicated that the addition of a hydroxy
lgroup (
3) on
ly increased the potency s
li
ght
ly a
gainst the neurona
l isoform over the parent compound (
1).Rationa
lizations for the sma
ll increase in potency are consistent with other chan
ges in the crysta
l structures.